SIREN : 408526473
KRAUS BIOMEDICAL is a French company founded 29 years ago, specialized in the sector Traduction et interprétation. Based in PUTEAUX (92800), this company of category PME shows in 2015 a revenue of 676 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|
| Revenue | N/C | N/C | 675 997 € | 631 976 € |
| Net income | 10 776 € | 36 328 € | 56 649 € | 28 655 € |
| EBITDA | N/C | N/C | 72 978 € | 38 767 € |
| Net margin | N/C | N/C | 8.4% | 4.5% |
In 2017, KRAUS BIOMEDICAL generates positive net income of 11 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2014-2017: 29 k€ -> 11 k€.
10 776 €
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 99%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
0.434%
98.649%
In 2017, the debt ratio of KRAUS BIOMEDICAL (0.43) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
In 2017, the financial autonomy of KRAUS BIOMEDICAL (98.7%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
In 2015, the repayment capacity of KRAUS BIOMEDICAL (0.15) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.
The liquidity ratio (= Current assets / Current liabilities) stands at 8116.89. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
8116.889
In 2017, the liquidity ratio of KRAUS BIOMEDICAL (8116.89) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
In 2015, the interest coverage of KRAUS BIOMEDICAL (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
0 €
0 j
0 j
0 j
Based on 178 transactions of similar company sales (all years), the value of KRAUS BIOMEDICAL is estimated at 53 442 € (range 18 402€ - 95 020€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 178 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare KRAUS BIOMEDICAL with other companies in the same sector:
Voir toutes les statistiques du secteur Traduction et interprétation
The revenue of KRAUS BIOMEDICAL in 2015 is 676 k€.
Yes, KRAUS BIOMEDICAL generated a net profit of 11 k€ in 2017.
The headquarters of KRAUS BIOMEDICAL is located in PUTEAUX (92800), in the department Hauts-de-Seine.
The tax return of KRAUS BIOMEDICAL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
KRAUS BIOMEDICAL operates in the sector Traduction et interprétation (NAF code 74.30Z). See the 'Sector positioning' section above to compare the company with its competitors.